Summary
Appropriate Use Criteria for 18F-FDG PET/CT for Initial Staging of Malignant Disease
Hossein Jadvar (University of Southern California)
Michael B. Atkins (Georgetown-Lombardi Comprehensive Cancer Center)
Twyla Bartel (Global Advanced Imaging, PLLC, Arkansas)
Lioe Fee de Geus-Oei (TU Delft - RST/Radiation, Science and Technology)
Elizabeth H. Dibble (Brown University)
Balazs Halmos (Montefiore Einstein Comprehensive Cancer Center, Bronx, New York,)
Rathan M. Subramaniam (University of Notre Dame Australia, Sydney, Duke University)
Gary A. Ulaner (University of Southern California)
Sofia Carrilho Vaz (Champalimaud Clinical Center, Leiden University Medical Center)
undefined More Authors (External organisation)
More Info
expand_more
Other than for strictly personal use, it is not permitted to download, forward or distribute the text or part of it, without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license such as Creative Commons.
Abstract
The appropriate use criteria (AUC) documents are intended to aid medical practitioners in the appropriate use of imaging technology in specific clinical scenarios based on rigorous appraisal of the available published evidence. The purpose of this document is to summarize the appropriate use of PET/CT with 18F-FDG in the initial staging of malignant disease. A multidisciplinary expert panel convened to appraise an independently performed systematic review and develop the AUC for initial staging of head and neck cancer, lung cancer, breast cancer, esophageal cancer, colorectal cancer, pancreatic cancer, melanoma, lymphoma, myeloma, and sarcoma with an appropriateness score for each clinical scenario established by using a modified Delphi process (Table 1). The full document including the methodology details, discussion of evidence, appendices, and the supplemental material can be accessed at https://snmmi.org/Web/Clinical-Practice/Appropriate-Use-Criteria/Articles/Appropriate_Use_Criteria_for_18F-FDG_PET_CT_for_Initial_Staging_of_Malignant_Disease.